Clinical Trials Directory

Trials / Completed

CompletedNCT00237887

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

A Phase III, Multicenter Study of the Efficacy and Safety of Adalimumab Treatment in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
1,212 (actual)
Sponsor
Abbott · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A Phase III, Multicenter Study of the Efficacy and Safety of Adalimumab Treatment in Subjects with Moderate to Severe Chronic Plaque Psoriasis

Conditions

Interventions

TypeNameDescription
DRUGadalimumab

Timeline

Start date
2004-12-01
First posted
2005-10-13
Last updated
2007-08-29

Source: ClinicalTrials.gov record NCT00237887. Inclusion in this directory is not an endorsement.

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis (NCT00237887) · Clinical Trials Directory